Clinical Trials Browser

Phase 1/2 × Resveratrol × Clear all

NCT02261844 2017-03-30

Resveratrol and Human Hepatocyte Function in Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Colorectal Neoplasms